Extensive papillomas along the epiglottis, bilateral aryepiglottic
folds, and bilateral true and false cords with extension into the
subglottis (left) and residual small papillomas on the laryngeal surface
of the epiglottis after 2 months and 3 cycles of bevacizumab (right).